I Goldberg Selected Research

I Goldberg Research Topics

Disease

16	Neoplasms (Cancer) 10/2004 - 01/2000
10	Carcinoma (Carcinomatosis) 12/2001 - 01/2000
5	Neoplasm Metastasis (Metastasis) 10/2004 - 04/2000
3	Hyperglycemia 02/2009 - 05/2000
3	Glaucoma 05/2008 - 10/2000
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 05/2008 - 10/2000
3	Ocular Hypertension (Glaucoma, Suspect) 05/2008 - 10/2000
3	Pemphigus (Pemphigus Vulgaris) 04/2004 - 01/2001
3	Atherosclerosis 07/2003 - 03/2000
2	Inflammation (Inflammations) 02/2009 - 08/2001
2	Breast Neoplasms (Breast Cancer) 10/2004 - 10/2000
2	Ganglion Cysts (Ganglion) 07/2004 - 07/2001
2	Infarction (Infarctions) 07/2003 - 12/2001
2	Myocardial Infarction 07/2003 - 12/2001
2	Adenocarcinoma 11/2001 - 04/2000
1	Failure to Thrive 01/2020
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 01/2020
1	Eosinophilia 06/2019
1	Drug Eruptions (Drug Eruption) 06/2019
1	Nevus (Nevi) 06/2019
1	Cutaneous Mastocytosis 07/2018
1	Chanarin-Dorfman Syndrome 01/2012
1	Ichthyosis (Xeroderma) 01/2012
1	Factor XI Deficiency (Hemophilia C) 09/2011
1	Hemorrhage 09/2011
1	Hypersensitivity (Allergy) 09/2011
1	Thrombophilia 09/2011
1	Hyperpigmentation 05/2008
1	Drug-Related Side Effects and Adverse Reactions 05/2008
1	Wilms Tumor (Wilm's Tumor) 10/2004
1	Sepsis (Septicemia) 10/2004
1	Hirschsprung Disease (Hirschsprung's Disease) 07/2004
1	Acantholysis 07/2003
1	Dyskinesias (Dyskinesia) 12/2001
1	Coronary Occlusion 12/2001

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 12/2001 - 01/2000
3	LipidsIBA 01/2012 - 06/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003 - 02/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001 - 01/2000
3	Proteins (Proteins, Gene)FDA Link 12/2001 - 12/2000
3	Transcription Factors (Transcription Factor)IBA 12/2001 - 05/2000
3	Matrix Metalloproteinases (MMPs)IBA 11/2001 - 03/2001
3	Cadherins (E-Cadherin)IBA 09/2001 - 12/2000
2	Keratins (Keratin)IBA 01/2020 - 06/2000
2	AntigensIBA 10/2004 - 04/2000
2	Phenol (Carbolic Acid)FDA Link 07/2003 - 01/2001
2	AntibodiesIBA 07/2003 - 04/2000
2	Peptide Hydrolases (Proteases)FDA Link 07/2003 - 03/2001
2	Complement System Proteins (Complement)IBA 07/2003 - 04/2000
2	Interleukin-8 (Interleukin 8)IBA 12/2001 - 01/2000
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2001 - 03/2001
2	beta CateninIBA 09/2001 - 07/2001
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2001 - 03/2000
2	gamma Catenin (Plakoglobin)IBA 07/2001 - 12/2000
2	ErbB Receptors (EGF Receptor)IBA 05/2001 - 12/2000
2	Streptozocin (Streptozotocin)FDA Link 06/2000 - 05/2000
2	LDL Receptors (LDL Receptor)IBA 06/2000 - 03/2000
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2000 - 03/2000
2	oxidized low density lipoproteinIBA 06/2000 - 03/2000
2	Monoclonal AntibodiesIBA 04/2000 - 03/2000
1	Indicators and Reagents (Reagents)IBA 06/2019
1	Pharmaceutical PreparationsIBA 06/2019
1	pimecrolimus (Elidel)FDA Link 07/2018
1	Acitretin FDA Link 01/2012
1	A-factor (Streptomyces)IBA 09/2011
1	Dacarbazine (DIC)FDA LinkGeneric 09/2011
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2011
1	Fibrinogen (Factor I)FDA Link 02/2009
1	C-Reactive ProteinIBA 02/2009
1	Glucose (Dextrose)FDA LinkGeneric 02/2009
1	LDL CholesterolIBA 02/2009
1	Latanoprost (Xalatan)FDA Link 05/2008
1	Retinaldehyde (Retinal)IBA 04/2006
1	Growth Factor ReceptorsIBA 10/2004
1	Calbindin 2IBA 07/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2004
1	HLA-B38 AntigenIBA 04/2004
1	HLA-B35 Antigen (HLA B35 Antigen)IBA 04/2004
1	Sulfhydryl Compounds (Thiols)IBA 07/2003
1	Pyridinolcarbamate (P23)IBA 07/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2003
1	CytokinesIBA 07/2003
1	PhenolsIBA 07/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2003
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2001
1	Integrin alphaVIBA 12/2001
1	Insulin-Like PeptidesIBA 12/2001
1	DNA (Deoxyribonucleic Acid)IBA 12/2001
1	DesminIBA 12/2001
1	Troponin IIBA 12/2001
1	Integrin beta1IBA 12/2001
1	IntegrinsIBA 12/2001
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2001

Therapy/Procedure

5	Therapeutics 08/2001 - 05/2000
1	Enteral Nutrition (Feeding, Tube) 01/2020
1	Arthroplasty 09/2011
1	Thyroidectomy 09/2011
1	Radiotherapy 10/2004
1	Drug Therapy (Chemotherapy) 10/2004
1	Ligation 07/2003